Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.180
+0.020 (0.93%)
At close: Jul 3, 2025, 1:00 PM
2.160
-0.020 (-0.92%)
After-hours: Jul 3, 2025, 4:06 PM EDT

Oramed Pharmaceuticals Statistics

Total Valuation

ORMP has a market cap or net worth of $89.05 million. The enterprise value is -$41.29 million.

Market Cap 89.05M
Enterprise Value -41.29M

Important Dates

The next estimated earnings date is Friday, August 15, 2025, after market close.

Earnings Date Aug 15, 2025
Ex-Dividend Date n/a

Share Statistics

ORMP has 40.85 million shares outstanding. The number of shares has decreased by -0.05% in one year.

Current Share Class 40.85M
Shares Outstanding 40.85M
Shares Change (YoY) -0.05%
Shares Change (QoQ) +1.38%
Owned by Insiders (%) 14.15%
Owned by Institutions (%) 12.27%
Float 32.05M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 44.61
Forward PS n/a
PB Ratio 0.63
P/TBV Ratio 0.63
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 23.94, with a Debt / Equity ratio of 0.00.

Current Ratio 23.94
Quick Ratio 23.83
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -54.86

Financial Efficiency

Return on equity (ROE) is -18.51% and return on invested capital (ROIC) is -5.29%.

Return on Equity (ROE) -18.51%
Return on Assets (ROA) -5.10%
Return on Invested Capital (ROIC) -5.29%
Return on Capital Employed (ROCE) -10.08%
Revenue Per Employee $153,846
Profits Per Employee -$2.17M
Employee Count 13
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

In the past 12 months, ORMP has paid $3.77 million in taxes.

Income Tax 3.77M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -15.34% in the last 52 weeks. The beta is 1.62, so ORMP's price volatility has been higher than the market average.

Beta (5Y) 1.62
52-Week Price Change -15.34%
50-Day Moving Average 2.21
200-Day Moving Average 2.30
Relative Strength Index (RSI) 49.72
Average Volume (20 Days) 77,171

Short Selling Information

The latest short interest is 475,250, so 1.16% of the outstanding shares have been sold short.

Short Interest 475,250
Short Previous Month 489,422
Short % of Shares Out 1.16%
Short % of Float 1.48%
Short Ratio (days to cover) 5.71

Income Statement

In the last 12 months, ORMP had revenue of $2.00 million and -$28.24 million in losses. Loss per share was -$0.71.

Revenue 2.00M
Gross Profit 13,000
Operating Income -14.32M
Pretax Income 10.46M
Net Income -28.24M
EBITDA -14.15M
EBIT -14.32M
Loss Per Share -$0.71
Full Income Statement

Balance Sheet

The company has $130.64 million in cash and $301,000 in debt, giving a net cash position of $130.34 million or $3.19 per share.

Cash & Cash Equivalents 130.64M
Total Debt 301,000
Net Cash 130.34M
Net Cash Per Share $3.19
Equity (Book Value) 139.89M
Book Value Per Share 3.45
Working Capital 125.98M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.46 million and capital expenditures -$19,000, giving a free cash flow of -$10.47 million.

Operating Cash Flow -10.46M
Capital Expenditures -19,000
Free Cash Flow -10.47M
FCF Per Share -$0.26
Full Cash Flow Statement

Margins

Gross Margin 0.65%
Operating Margin -715.95%
Pretax Margin -1,225.60%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ORMP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.05%
Shareholder Yield 0.05%
Earnings Yield -31.71%
FCF Yield -11.76%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on January 23, 2013. It was a reverse split with a ratio of 0.083333:1.

Last Split Date Jan 23, 2013
Split Type Reverse
Split Ratio 0.083333:1

Scores

ORMP has an Altman Z-Score of 6.53 and a Piotroski F-Score of 3.

Altman Z-Score 6.53
Piotroski F-Score 3